Clinical data of Domagala’s group showed that nuclear PARP1 expression was upregulated in most breast tumors, while the overexpression of nuclear–cytoplasmic PARP1 was present only in a small percentage of breast tumors [26]. The gene discussed is PARP1; the disease is breast neoplasm.